International Guideline Harmonization Group
  • Home
  • About IGHG
    • Members
      • Core group
      • Guideline panels
        • Breast cancer
        • Cardiomyopathy
        • Premature ovarian insufficiency
        • Male gonadotoxicity
        • Thyroid cancer
        • Ototoxicty
        • Obstetric care
        • Central nervous system neoplasms
        • Fatigue, mental health and psychosocial problems
        • Fertility preservation
        • Hypothalamic-pituitary dysfunction
        • Coronary artery disease
        • Metabolic syndrome
        • Pulmonary dysfunction
        • Bone mineral density
        • Hepatic toxicity
        • Nephrotoxicity
        • Neurocognitive problems
        • Colorectal cancer
        • Thyroid dysfunction
        • Splenic dysfunction
        • Dexrazoxane cardioprotection
        • Growth hormone treatment
        • COVID-19 Statement
    • Collaborators
    • Funding sources
    • Methods
      • Process
      • Grading system
      • Topic selection
      • Publication
      • Handbook
  • Guidelines
    • Topics
      • Breast cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Cardiomyopathy
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Premature ovarian insufficiency
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Male gonadotoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Thyroid cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Ototoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Obstetric care
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Central nervous system neoplasms
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Fatigue
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Psychosocial problems
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Mental health problems
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Coronary artery disease
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Fertility preservation
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publications
        • Guideline panel
      • Bone mineral density
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Hepatic toxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Hypothalamic-pituitary dysfunction
        • Guideline panel
      • Metabolic syndrome
        • Guideline panel
      • Nephrotoxicity
        • Guideline panel
      • Colorectal cancer
        • Guideline panel
      • Neurocognitive problems
        • Guideline panel
      • Pulmonary dysfunction
        • Guideline panel
      • Splenic dysfunction
        • Guideline panel
      • Dexrazoxane cardioprotection
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Growth hormone treatment
      • Thyroid dysfunction
        • Guideline panel
      • COVID-19 Statement
  • Patient education
  • News
  • Meetings
  • Contact

Methods

Home International Guideline Harmonization Group Methods Handbook

  • Members
    • Core group
    • Guideline panels
      • Breast cancer
      • Cardiomyopathy
      • Premature ovarian insufficiency
      • Male gonadotoxicity
      • Thyroid cancer
      • Ototoxicty
      • Obstetric care
      • Central nervous system neoplasms
      • Fatigue, mental health and psychosocial problems
      • Fertility preservation
      • Hypothalamic-pituitary dysfunction
      • Coronary artery disease
      • Metabolic syndrome
      • Pulmonary dysfunction
      • Bone mineral density
      • Hepatic toxicity
      • Nephrotoxicity
      • Neurocognitive problems
      • Colorectal cancer
      • Thyroid dysfunction
      • Splenic dysfunction
      • Dexrazoxane cardioprotection
      • Growth hormone treatment
      • COVID-19 Statement
  • Collaborators
  • Funding sources
  • Methods
    • Process
    • Grading system
    • Topic selection
    • Publication
    • Handbook

Handbook

IGHG Handbook for guideline development_Version 4_April 2021

  • Contact
  • Disclaimer

© International Guideline Harmonization Group